Skip to main content

. 1969 Apr;53(4):239–245. doi: 10.1136/bjo.53.4.239

Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.

J S Cant, D R Lewis

PMCID: PMC1207306 PMID: 5818670

239

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cant J. S., Lewis D. R., Harrison M. T. Treatment of dysthyroid ophthalmopathy with local guanethidine. Br J Ophthalmol. 1969 Apr;53(4):233–238. doi: 10.1136/bjo.53.4.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
Crombie A. L., Lawson A. A. Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction. Br Med J. 1967 Dec 9;4(5579):592–595. doi: 10.1136/bmj.4.5579.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
Gay A. J., Salmon M. L., Wolkstein M. A. Topical sympatholytic therapy for pathologic lid retraction. Arch Ophthalmol. 1967 Mar;77(3):341–344. doi: 10.1001/archopht.1967.00980020343009. [DOI] [PubMed] [Google Scholar]
Gay A. J., Wolkstein M. A. Topical guanethidine therapy for endocrine lid retraction. Arch Ophthalmol. 1966 Sep;76(3):364–367. doi: 10.1001/archopht.1966.03850010366012. [DOI] [PubMed] [Google Scholar]
OOSTERHUIS J. A. Guanethidine (Ismelin) in ophthalmology. II. Clinical application in glaucoma. Arch Ophthalmol. 1962 Jun;67:802–810. doi: 10.1001/archopht.1962.00960020802016. [DOI] [PubMed] [Google Scholar]
Sneddon J. M., Turner P. Adrenergic blockade and the eye signs of thyrotoxicosis. Lancet. 1966 Sep 3;2(7462):525–527. doi: 10.1016/s0140-6736(66)92881-9. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES